Hyperthermia may Decrease the Development of Telangiectasia After Radiotherapy
Authors:
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 14 (1) , 57-64
Abstract
Case report: A patient with recurrent breast cancer was reirradiated twice on adjacent fields with a time interval of 9 months. The first time she was treated with reirradiation alone, the second time with reirradiation plus hyperthermia. The reirradiation schedule for both fields was 8 × 4 Gy in 4 weeks. Both fields overlapped partly with the field of postoperative radiotherapy, which was applied 57 and 66 months earlier to a total dose of 40.5 Gy. Results: During the 52 to 61 months follow—up, a remarkable difference in telangiectasia development, between the parts of the reirradiation fields overlapping with the primary radiotherapy field, became apparent. Telangiectasia was observed 9 months after treatment with reirradiation alone and progressed to confluent in 47 months after treatment. In the reirradiation plus hyperthermia area, the maximum observed telangiectasia was slight until 52 months after treatment. Discussion: The difference in the development of telangiectasia between these fields cannot be explained by differences in any of the known radiation treatment related prognostic factors. A protective effect by hyperthermia has been suggested by Haveman and coworkers, who have shown experimentally that heat treatment leads to enhanced proliferation of endothelial cells, thereby inducing a fast repo pulation and replacement of X-ray damaged cells. Conclusion: This difference in telangiectasia formation is an interesting observation. Whether such a protective effect of hyperthermia is of general relevance has to become clear from more extensive clinical studies.Keywords
This publication has 11 references indexed in Scilit:
- Prognostic factors for acute and late skin reactions in radiotheraphy patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanomaThe Lancet, 1995
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-upRadiotherapy and Oncology, 1989
- The current and potential role of hyperthermia in radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Quality assurance guidelines for ESHO protocolsInternational Journal of Hyperthermia, 1989
- Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988
- Cell Proliferation in the Murine Epidermis and Subcutaneous Vascular Endothelium after HyperthermiaInternational Journal of Radiation Biology, 1988
- Effects of Hyperthermia and X-irradiation on Mouse Stromal TissueInternational Journal of Radiation Biology, 1986